Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre ® in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitus.
Luciana Ribeiro BahiaKarla F MelloLívia Lovato Pires LemosNaiane Lima CostaEduardo MulinariDomingos Augusto Cherino MalerbiPublished in: Diabetology & metabolic syndrome (2023)
Our findings demonstrated that FSL is cost-effective in T1DM and T2DM for acute diabetic complications, from a SUS perspective. CGM with FSL can promote safe, convenient, and cost-effective glucose monitoring, therefore contributing to the improvement of the incidence of complications and quality of life.